IL117075A0 - Compounds having growth hormone releasing properties pharmaceutical compositions containing them and their use - Google Patents
Compounds having growth hormone releasing properties pharmaceutical compositions containing them and their useInfo
- Publication number
- IL117075A0 IL117075A0 IL11707596A IL11707596A IL117075A0 IL 117075 A0 IL117075 A0 IL 117075A0 IL 11707596 A IL11707596 A IL 11707596A IL 11707596 A IL11707596 A IL 11707596A IL 117075 A0 IL117075 A0 IL 117075A0
- Authority
- IL
- Israel
- Prior art keywords
- compounds
- pharmaceutical compositions
- compositions containing
- growth hormone
- hormone releasing
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
- C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
- C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D213/60—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D213/72—Nitrogen atoms
- C07D213/75—Amino or imino radicals, acylated by carboxylic or carbonic acids, or by sulfur or nitrogen analogues thereof, e.g. carbamates
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C335/00—Thioureas, i.e. compounds containing any of the groups, the nitrogen atoms not being part of nitro or nitroso groups
- C07C335/04—Derivatives of thiourea
- C07C335/16—Derivatives of thiourea having nitrogen atoms of thiourea groups bound to carbon atoms of six-membered aromatic rings of a carbon skeleton
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D215/00—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems
- C07D215/02—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom
- C07D215/16—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D215/38—Nitrogen atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D257/00—Heterocyclic compounds containing rings having four nitrogen atoms as the only ring hetero atoms
- C07D257/02—Heterocyclic compounds containing rings having four nitrogen atoms as the only ring hetero atoms not condensed with other rings
- C07D257/04—Five-membered rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D285/00—Heterocyclic compounds containing rings having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by groups C07D275/00 - C07D283/00
- C07D285/01—Five-membered rings
- C07D285/02—Thiadiazoles; Hydrogenated thiadiazoles
- C07D285/04—Thiadiazoles; Hydrogenated thiadiazoles not condensed with other rings
- C07D285/06—1,2,3-Thiadiazoles; Hydrogenated 1,2,3-thiadiazoles
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
DK14895 | 1995-02-09 |
Publications (1)
Publication Number | Publication Date |
---|---|
IL117075A0 true IL117075A0 (en) | 1996-06-18 |
Family
ID=8090312
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
IL11707596A IL117075A0 (en) | 1995-02-09 | 1996-02-08 | Compounds having growth hormone releasing properties pharmaceutical compositions containing them and their use |
Country Status (4)
Country | Link |
---|---|
AU (1) | AU4534596A (fr) |
IL (1) | IL117075A0 (fr) |
WO (1) | WO1996024580A1 (fr) |
ZA (1) | ZA961007B (fr) |
Families Citing this family (14)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
TW432073B (en) * | 1995-12-28 | 2001-05-01 | Pfizer | Pyrazolopyridine compounds |
KR100699404B1 (ko) | 1999-02-18 | 2007-03-23 | 가켄 세야쿠 가부시키가이샤 | 성장 호르몬 분비촉진제로서의 신규 아미드 유도체 |
DE60140285D1 (de) | 2000-05-31 | 2009-12-10 | Pfizer Prod Inc | Verwendung von Wachstumshormonsekretagoga zur Förderung der Beweglichkeit des Verdauungstrakts |
DZ3415A1 (fr) | 2000-08-31 | 2002-03-07 | Chiron Corp | Guanidinobenzamides comme mc4-r agonistes. |
EP1767525A1 (fr) | 2001-04-09 | 2007-03-28 | Novartis Vaccines and Diagnostics, Inc. | Composés guanidino comme agonistes du récepteur 4 de la mélanocortine (MC4-R) |
MXPA04011557A (es) | 2002-05-23 | 2005-07-05 | Chiron Corp | Compuestos de quinazolinona sustituida. |
JP2007501861A (ja) | 2003-05-23 | 2007-02-01 | カイロン コーポレイション | Mc4−rアゴニストとしてのグアニジノ置換キナゾリノン化合物 |
US7476653B2 (en) | 2003-06-18 | 2009-01-13 | Tranzyme Pharma, Inc. | Macrocyclic modulators of the ghrelin receptor |
MXPA06005736A (es) | 2003-11-19 | 2006-12-14 | Chiron Corp | Compuestos de quinazolinona con bioacumulacion reducida. |
CU23558A1 (es) | 2006-02-28 | 2010-07-20 | Ct Ingenieria Genetica Biotech | Compuestos análogos a los secretagogos peptidicos de la hormona de crecimiento |
ES2602789T3 (es) | 2007-02-09 | 2017-02-22 | Ocera Therapeutics, Inc. | Productos intermedios conectores para la síntesis de moduladores macrocíclicos del receptor de la grelina |
WO2013190520A2 (fr) | 2012-06-22 | 2013-12-27 | The General Hospital Corporation | Agents de libération de gh dans le traitement d'une sténose vasculaire et d'états associés |
US9119832B2 (en) | 2014-02-05 | 2015-09-01 | The Regents Of The University Of California | Methods of treating mild brain injury |
WO2017075535A1 (fr) | 2015-10-28 | 2017-05-04 | Oxeia Biopharmaceuticals, Inc. | Méthodes de traitement de troubles neurodégénératifs |
-
1996
- 1996-02-06 WO PCT/DK1996/000058 patent/WO1996024580A1/fr active Application Filing
- 1996-02-06 AU AU45345/96A patent/AU4534596A/en not_active Abandoned
- 1996-02-08 ZA ZA961007A patent/ZA961007B/xx unknown
- 1996-02-08 IL IL11707596A patent/IL117075A0/xx unknown
Also Published As
Publication number | Publication date |
---|---|
ZA961007B (en) | 1996-08-29 |
WO1996024580A1 (fr) | 1996-08-15 |
AU4534596A (en) | 1996-08-27 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
IL116923A (en) | Compounds with growth hormone releasing properties and pharmaceutical compositions containing them | |
IL121621A0 (en) | Neurotrophic compounds pharmaceutical compositions containing them and their use | |
IL122618A0 (en) | Substituted imidazolylacetonitrile compounds their preparation and pharmaceutical compositions containing them | |
IL117860A0 (en) | Substituted 1-phenyl-3-pyrazolecarboxamides their preparation and pharmaceutical compositions containing them | |
IL119078A (en) | Substituted benzylaminopiperidine compounds and pharmaceutical compositions comprising them | |
IL113389A0 (en) | 1,4-Benzodiazepine compounds, pharmaceutical compositions containing them, their preparation and use | |
IL116775A (en) | Tricyclic azolobenzodiazepines and similar compounds their preparation and pharmaceutical compositions containing them | |
IL121236A0 (en) | Cycloalkano-pyridines their preparation and pharmaceutical compositions containing them | |
IL105220A0 (en) | Cyclohexanylidene compounds and pharmaceutical compositions containing them | |
IL114622A0 (en) | Heteroaryl-oxazolidinones and pharmaceutical compositions containing them | |
IL122293A0 (en) | Substituted 4-phenylaminothiazoles their preparation and pharmaceutical compositions containing them | |
AP9701160A0 (en) | Compounds and pharmaceutical compositions containing them | |
IL119559A0 (en) | Purin -6- one derivatives their preparation and pharmaceutical compositions containing them | |
IL115905A0 (en) | Sordarin derivatives their preparation and pharmaceutical compositions containing them | |
IL117554A0 (en) | Imidazoquinazolines their preparation and pharmaceutical compositions containing them | |
IL117981A0 (en) | Compositions containing 2-oxetanones their preparation and use | |
IL117075A0 (en) | Compounds having growth hormone releasing properties pharmaceutical compositions containing them and their use | |
IL117815A0 (en) | Ascomycins their preparation and pharmaceutical compositions containing them | |
IL108073A0 (en) | Substituted 6-azaandrostenones their preparation and pharmaceutical compositions containing them | |
IL113366A0 (en) | 1,5-benzodiazepine compounds, their preparation and use, and pharmaceutical compositions containing them | |
IL117076A0 (en) | Compounds having growth hormone releasing properties pharmaceutical compositions containing them and their use | |
IL114623A0 (en) | Substituted triazolylmethylphenylnaph-thyridones their preparation and pharmaceutical compositions containing them | |
IL119371A0 (en) | Sulfonylaminopyrimidines their preparation and pharmaceutical compositions containing them | |
IL118672A0 (en) | Benzisothiazolyl-substituted aminomethylchromans their preparation and pharmaceutical compositions containing them | |
IL107611A0 (en) | Steroid compounds and pharmaceutical compositions containing them |